ABEO vs ROP · rev $3.5M vs P/E 41, rev $1.88B
Abeona Therapeutics Inc (ABEO) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ABEO currently screens at market cap $301.8M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ABEO and ROP stock pages for the full models.
Not investment advice.